BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 4 hits with Last Name = 'coulie' and Initial = 'b'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Promotilin


(Homo sapiens (Human))
BDBM85389
PNG
(CAS_52906-92-0 | Motilin)
Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#16]-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#8])=O |r|
Show InChI InChI=1S/C120H188N34O35S/c1-9-64(6)97(152-114(184)86-31-22-53-154(86)117(187)96(63(4)5)151-99(169)70(123)56-66-23-12-10-13-24-66)115(185)150-84(57-67-25-14-11-15-26-67)113(183)153-98(65(7)155)116(186)149-83(58-68-32-34-69(156)35-33-68)101(171)135-60-91(161)136-75(39-45-93(163)164)105(175)147-82(55-62(2)3)111(181)145-77(37-43-88(125)158)106(176)140-73(29-20-51-132-119(128)129)103(173)146-80(48-54-190-8)110(180)142-76(36-42-87(124)157)107(177)144-79(41-47-95(167)168)108(178)139-72(28-17-19-50-122)102(172)143-78(40-46-94(165)166)109(179)141-74(30-21-52-133-120(130)131)104(174)148-85(59-90(127)160)112(182)138-71(27-16-18-49-121)100(170)134-61-92(162)137-81(118(188)189)38-44-89(126)159/h10-15,23-26,32-35,62-65,70-86,96-98,155-156H,9,16-22,27-31,36-61,121-123H2,1-8H3,(H2,124,157)(H2,125,158)(H2,126,159)(H2,127,160)(H,134,170)(H,135,171)(H,136,161)(H,137,162)(H,138,182)(H,139,178)(H,140,176)(H,141,179)(H,142,180)(H,143,172)(H,144,177)(H,145,181)(H,146,173)(H,147,175)(H,148,174)(H,149,186)(H,150,185)(H,151,169)(H,152,184)(H,153,183)(H,163,164)(H,165,166)(H,167,168)(H,188,189)(H4,128,129,132)(H4,130,131,133)/t64-,65+,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,96-,97-,98-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
2.30n/an/an/an/an/an/an/an/a



Mayo Clinic in Scottsdale

Curated by PDSP Ki Database




J Pharmacol Exp Ther 313: 1101-8 (2005)


Article DOI: 10.1124/jpet.104.081562
BindingDB Entry DOI: 10.7270/Q28K77N1
More data for this
Ligand-Target Pair
Promotilin


(Homo sapiens (Human))
BDBM86675
PNG
(CAS_0 | NSC_0 | [Bpa5,Ile13]Motilin | [L-Bpa5,Ile1...)
Show SMILES [#6]-[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#8])=O)-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccc(-[#8])cc1)-[#7]-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccc(cc1)-[#6](=O)-c1ccccc1)-[#7]-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6@@H](-[#6])-[#6]-[#6])-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#6])=[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#8])=O |r,w:127.132|
Show InChI InChI=1S/C129H196N34O35/c1-11-69(7)105(123(193)148-80(43-49-95(133)166)71(9)145-85(46-52-101(172)173)114(184)150-82(31-20-22-56-131)112(182)153-88(48-54-103(176)177)117(187)151-83(32-23-57-141-128(137)138)113(183)156-93(64-98(136)169)120(190)149-81(30-19-21-55-130)110(180)143-66-100(171)147-89(127(197)198)45-51-97(135)168)160-118(188)84(33-24-58-142-129(139)140)152-116(186)87(44-50-96(134)167)154-119(189)90(60-67(3)4)155-115(185)86(47-53-102(174)175)146-99(170)65-144-111(181)91(62-75-37-41-78(165)42-38-75)157-125(195)107(72(10)164)162-121(191)92(63-74-35-39-77(40-36-74)108(178)76-28-17-14-18-29-76)158-124(194)106(70(8)12-2)161-122(192)94-34-25-59-163(94)126(196)104(68(5)6)159-109(179)79(132)61-73-26-15-13-16-27-73/h13-18,26-29,35-42,67-70,72,79-94,104-107,164-165H,11-12,19-25,30-34,43-66,130-132H2,1-10H3,(H2,133,166)(H2,134,167)(H2,135,168)(H2,136,169)(H,143,180)(H,144,181)(H,146,170)(H,147,171)(H,148,193)(H,149,190)(H,150,184)(H,151,187)(H,152,186)(H,153,182)(H,154,189)(H,155,185)(H,156,183)(H,157,195)(H,158,194)(H,159,179)(H,160,188)(H,161,192)(H,162,191)(H,172,173)(H,174,175)(H,176,177)(H,197,198)(H4,137,138,141)(H4,139,140,142)/t69?,70-,72+,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,104-,105-,106-,107-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
50n/an/an/an/an/an/an/an/a



Mayo Clinic in Scottsdale

Curated by PDSP Ki Database




J Pharmacol Exp Ther 313: 1101-8 (2005)


Article DOI: 10.1124/jpet.104.081562
BindingDB Entry DOI: 10.7270/Q28K77N1
More data for this
Ligand-Target Pair
Promotilin


(Homo sapiens (Human))
BDBM86675
PNG
(CAS_0 | NSC_0 | [Bpa5,Ile13]Motilin | [L-Bpa5,Ile1...)
Show SMILES [#6]-[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#8])=O)-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccc(-[#8])cc1)-[#7]-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccc(cc1)-[#6](=O)-c1ccccc1)-[#7]-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6@@H](-[#6])-[#6]-[#6])-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#6])=[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#8])=O |r,w:127.132|
Show InChI InChI=1S/C129H196N34O35/c1-11-69(7)105(123(193)148-80(43-49-95(133)166)71(9)145-85(46-52-101(172)173)114(184)150-82(31-20-22-56-131)112(182)153-88(48-54-103(176)177)117(187)151-83(32-23-57-141-128(137)138)113(183)156-93(64-98(136)169)120(190)149-81(30-19-21-55-130)110(180)143-66-100(171)147-89(127(197)198)45-51-97(135)168)160-118(188)84(33-24-58-142-129(139)140)152-116(186)87(44-50-96(134)167)154-119(189)90(60-67(3)4)155-115(185)86(47-53-102(174)175)146-99(170)65-144-111(181)91(62-75-37-41-78(165)42-38-75)157-125(195)107(72(10)164)162-121(191)92(63-74-35-39-77(40-36-74)108(178)76-28-17-14-18-29-76)158-124(194)106(70(8)12-2)161-122(192)94-34-25-59-163(94)126(196)104(68(5)6)159-109(179)79(132)61-73-26-15-13-16-27-73/h13-18,26-29,35-42,67-70,72,79-94,104-107,164-165H,11-12,19-25,30-34,43-66,130-132H2,1-10H3,(H2,133,166)(H2,134,167)(H2,135,168)(H2,136,169)(H,143,180)(H,144,181)(H,146,170)(H,147,171)(H,148,193)(H,149,190)(H,150,184)(H,151,187)(H,152,186)(H,153,182)(H,154,189)(H,155,185)(H,156,183)(H,157,195)(H,158,194)(H,159,179)(H,160,188)(H,161,192)(H,162,191)(H,172,173)(H,174,175)(H,176,177)(H,197,198)(H4,137,138,141)(H4,139,140,142)/t69?,70-,72+,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,104-,105-,106-,107-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
50n/an/an/an/an/an/an/an/a



Mayo Clinic in Scottsdale

Curated by PDSP Ki Database




J Pharmacol Exp Ther 313: 1101-8 (2005)


Article DOI: 10.1124/jpet.104.081562
BindingDB Entry DOI: 10.7270/Q28K77N1
More data for this
Ligand-Target Pair
Promotilin


(Homo sapiens (Human))
BDBM86676
PNG
([D-Bpa5,Ile13]Motilin)
Show SMILES [#6]-[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#8])=O)-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccc(-[#8])cc1)-[#7]-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#6]-c1ccc(cc1)-[#6](=O)-c1ccccc1)-[#7]-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6@@H](-[#6])-[#6]-[#6])-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#6])=[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#8])=O |r,w:127.132|
Show InChI InChI=1S/C129H196N34O35/c1-11-69(7)105(123(193)148-80(43-49-95(133)166)71(9)145-85(46-52-101(172)173)114(184)150-82(31-20-22-56-131)112(182)153-88(48-54-103(176)177)117(187)151-83(32-23-57-141-128(137)138)113(183)156-93(64-98(136)169)120(190)149-81(30-19-21-55-130)110(180)143-66-100(171)147-89(127(197)198)45-51-97(135)168)160-118(188)84(33-24-58-142-129(139)140)152-116(186)87(44-50-96(134)167)154-119(189)90(60-67(3)4)155-115(185)86(47-53-102(174)175)146-99(170)65-144-111(181)91(62-75-37-41-78(165)42-38-75)157-125(195)107(72(10)164)162-121(191)92(63-74-35-39-77(40-36-74)108(178)76-28-17-14-18-29-76)158-124(194)106(70(8)12-2)161-122(192)94-34-25-59-163(94)126(196)104(68(5)6)159-109(179)79(132)61-73-26-15-13-16-27-73/h13-18,26-29,35-42,67-70,72,79-94,104-107,164-165H,11-12,19-25,30-34,43-66,130-132H2,1-10H3,(H2,133,166)(H2,134,167)(H2,135,168)(H2,136,169)(H,143,180)(H,144,181)(H,146,170)(H,147,171)(H,148,193)(H,149,190)(H,150,184)(H,151,187)(H,152,186)(H,153,182)(H,154,189)(H,155,185)(H,156,183)(H,157,195)(H,158,194)(H,159,179)(H,160,188)(H,161,192)(H,162,191)(H,172,173)(H,174,175)(H,176,177)(H,197,198)(H4,137,138,141)(H4,139,140,142)/t69?,70-,72+,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92+,93-,94-,104-,105-,106-,107-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
420n/an/an/an/an/an/an/an/a



Mayo Clinic in Scottsdale

Curated by PDSP Ki Database




J Pharmacol Exp Ther 313: 1101-8 (2005)


Article DOI: 10.1124/jpet.104.081562
BindingDB Entry DOI: 10.7270/Q28K77N1
More data for this
Ligand-Target Pair